* To whom correspondence should be addressed.
Received March 22, 2006; Revision received March 29, 2006
Pyrogallol reversibly and noncompetitively inhibits the activity of the hepatitis C RNA-dependent RNA polymerase. Based on molecular modeling of the inhibitor binding in the active site of the enzyme, the inhibition was suggested to be realized via chelation of two magnesium cations involved in the catalysis at the stage of the phosphoryl residue transfer. The proposed model allowed us to purposefully synthesize new derivatives with higher inhibitory capacity.
KEY WORDS: hepatitis C virus, RNA-dependent RNA polymerase, pyrogallol derivatives, inhibition mechanism, molecular modelingDOI: 10.1134/S0006297906090112